New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
Over the past few decades, atherogenic dyslipidaemia has become one of the most common phenotypic presentations of lipid abnormalities, being strongly and unequivocally associated with an increased risk of cardiovascular (CV) disease. Despite the excellent results achieved from statin and non-statin...
Saved in:
Main Authors: | Alberto J Lorenzatti, Peter P Toth |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/a811fc3ce3924d8caabd2cbb418db7ca |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging Strategies for the Management of Atherogenic Dyslipidaemia
by: Anandita Agarwala, et al.
Published: (2020) -
Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
by: Ricardo Lopez Santi, et al.
Published: (2021) -
Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
by: Alberto J Lorenzatti
Published: (2021) -
Inflammation and Cardiovascular Disease: The Future
by: Natalie Arnold, et al.
Published: (2021) -
Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
by: Maki Komiyama, et al.
Published: (2021)